Most Read Articles
Roshini Claire Anthony, 4 days ago

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

6 days ago
Eating behaviours have been shown to moderate the relationship between cumulated risk factors in the first 1,000 days and adiposity outcomes at 6 years of age, which underscores modifiable behavioural targets for interventions, reports a study.
Stephen Padilla, 5 days ago
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.
Yesterday
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.

Abobotulinum toxin A injection improves outcomes in paediatric patients with neurogenic bladder

06 Feb 2020

Paediatric patients with neurogenic bladder may benefit from intradetrusor abobotulinum toxin A, which has been shown to improve cystometric capacity and maximum neurogenic detrusor overactivity in a recent study. This effect persists over multiple injections.

Additionally, “[c]ompliance is significantly improved in patients with low compliance bladder vs overactive bladder,” the authors said.

Of the 30 patients included in this study, 15 (50 percent) received multiple abobotulinum toxin A injections. Sixteen patients (53 patients) had an overactive bladder.

Administration of abobotulinum toxin A led to significant improvements in cystometric capacity (p<0.0001) and maximum neurogenic detrusor overactivity (p=0.0001). No significant change was observed in compliance overall (p=0.25). Urodynamic parameters did not significantly differ between first and last abobotulinum toxin A injections.

Improvement was comparable between the low compliance and overactive bladder groups in terms of cystometric capacity (p=0.05) and maximum neurogenic detrusor overactivity (p=0.25). Moreover, compliance significantly improved in the low compliance group compared with the overactive bladder group (p=0.016).

In this study, the authors carried out a single-centre retrospective review of paediatric patients with neurogenic bladder treated with abobotulinum toxin A. They collected videourodynamic data on cystometric capacity, maximum neurogenic detrusor overactivity pressure and compliance before and after the first abobotulinum toxin A administration and after the last administration.

Patients were then divided into low compliance and overactive bladder groups based on initial videourodynamic findings. Videourodynamic outcomes before and after abobotulinum A injections were compared using paired t-test. Bladder groups were compared using the Mann-Whitney U test.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

6 days ago
Eating behaviours have been shown to moderate the relationship between cumulated risk factors in the first 1,000 days and adiposity outcomes at 6 years of age, which underscores modifiable behavioural targets for interventions, reports a study.
Stephen Padilla, 5 days ago
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.
Yesterday
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.